No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
WGS250117P65000
- 2.10
- -0.55-20.75%
15min DelayClose Dec 23 16:00 ET
2.45High2.10Low
2.45Open2.65Pre Close5 Volume42 Open Interest65.00Strike Price1.16KTurnover89.98%IV17.67%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry2.10Extrinsic Value100Contract SizeAmericanOptions Type-0.2068Delta0.0159Gamma32.51Leverage Ratio-0.1017Theta-0.0114Rho-6.72Eff Leverage0.0569Vega
Intraday
- 5D
- Daily
News
Institutional Investors Control 59% of GeneDx Holdings Corp. (NASDAQ:WGS) and Were Rewarded Last Week After Stock Increased 3.5%
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?
GeneDx Announces Biogen, Praxis Precision Medicines And Stoke Therapeutics As The Founding Partners To Its Patient Access Program For Pediatric Epilepsy, Which Provides Access To Whole Exome Sequencing.
AppLovin, MicroStrategy, and 28 Other Stocks That Could Be Bubbles
Sleep Number, Getty Images, and More Stocks See Action From Activist Investors -- Barrons.com